Literature DB >> 17914240

The p53-MDM2 network: from oscillations to apoptosis.

Indrani Bose1, Bhaswar Ghosh.   

Abstract

The p53 protein is well-known for its tumour suppressor function. The p53-MDM2 negative feedback loop constitutes the core module of a network of regulatory interactions activated under cellular stress. In normal cells, the level of p53 proteins is kept low by MDM2, i.e. MDM2 negatively regulates the activity of p53. In the case of DNA damage, the p53-mediated pathways are activated leading to cell cycle arrest and repair of the DNA. If repair is not possible due to excessive damage, the p53-mediated apoptotic pathway is activated bringing about cell death. In this paper, we give an overview of our studies on the p53-MDM2 module and the associated pathways from a systems biology perspective. We discuss a number of key predictions, related to some specific aspects of cell cycle arrest and cell death, which could be tested in experiments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17914240     DOI: 10.1007/s12038-007-0103-3

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  25 in total

1.  A mathematical model of caspase function in apoptosis.

Authors:  M Fussenegger; J E Bailey; J Varner
Journal:  Nat Biotechnol       Date:  2000-07       Impact factor: 54.908

2.  p53-Mdm2 loop controlled by a balance of its feedback strength and effective dampening using ATM and delayed feedback.

Authors:  J Wagner; L Ma; J J Rice; W Hu; A J Levine; G A Stolovitzky
Journal:  Syst Biol (Stevenage)       Date:  2005-09

3.  A plausible model for the digital response of p53 to DNA damage.

Authors:  Lan Ma; John Wagner; John Jeremy Rice; Wenwei Hu; Arnold J Levine; Gustavo A Stolovitzky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

4.  Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.

Authors:  W J Song; M G Sullivan; R D Legare; S Hutchings; X Tan; D Kufrin; J Ratajczak; I C Resende; C Haworth; R Hock; M Loh; C Felix; D C Roy; L Busque; D Kurnit; C Willman; A M Gewirtz; N A Speck; J H Bushweller; F P Li; K Gardiner; M Poncz; J M Maris; D G Gilliland
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

5.  Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores.

Authors:  E Z Bagci; Y Vodovotz; T R Billiar; G B Ermentrout; I Bahar
Journal:  Biophys J       Date:  2005-12-09       Impact factor: 4.033

6.  Gene copy number and cell cycle arrest.

Authors:  Bhaswar Ghosh; Indrani Bose
Journal:  Phys Biol       Date:  2005-12-16       Impact factor: 2.583

7.  Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.

Authors:  S Venkatachalam; Y P Shi; S N Jones; H Vogel; A Bradley; D Pinkel; L A Donehower
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Inactivation of p21WAF1 sensitizes cells to apoptosis via an increase of both p14ARF and p53 levels and an alteration of the Bax/Bcl-2 ratio.

Authors:  Delphine Javelaud; Francoise Besancon
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

10.  Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos.

Authors:  B Novak; J J Tyson
Journal:  J Cell Sci       Date:  1993-12       Impact factor: 5.285

View more
  18 in total

1.  Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.

Authors:  Asfar S Azmi; Philip A Philip; A Aboukameel; Zhiwei Wang; Sanjeev Banerjee; Syed F Zafar; Anton-Scott Goustin; K Almhanna; Dajun Yang; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Curr Cancer Drug Targets       Date:  2010-05       Impact factor: 3.428

2.  Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers.

Authors:  Xingming Chen; Erich M Sturgis; Adel K El-Naggar; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2008-08-13       Impact factor: 4.944

3.  Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.

Authors:  Vitaly A Likhoshvai; Tamara M Khlebodarova; Sergei I Bazhan; Irina A Gainova; Valery A Chereshnev; Gennady A Bocharov
Journal:  BMC Genomics       Date:  2014-12-19       Impact factor: 3.969

4.  Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma.

Authors:  Xingming Chen; Erich M Sturgis; Dapeng Lei; Kristina Dahlstrom; Qingyi Wei; Guojun Li
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

5.  P53 gene mutation increases progastrin dependent colonic proliferation and colon cancer formation in mice.

Authors:  Vigneshwaran Ramanathan; Guangchun Jin; Christoph Benedikt Westphalen; Ashley Whelan; Alexander Dubeykovskiy; Shigeo Takaishi; Timothy C Wang
Journal:  Cancer Invest       Date:  2012-04-05       Impact factor: 2.176

6.  EphB3 limits the expansion of neural progenitor cells in the subventricular zone by regulating p53 during homeostasis and following traumatic brain injury.

Authors:  Michelle H Theus; Jerome Ricard; John R Bethea; Daniel J Liebl
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

Review 7.  The roles of E3 ligases in Hepatocellular carcinoma.

Authors:  Zongdong Yu; Hong Li; Jie Zhu; Haibiao Wang; Xiaofeng Jin
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

Review 8.  Functional roles of E3 ubiquitin ligases in prostate cancer.

Authors:  Yiting Zhao; Jinyun Li; Jun Chen; Meng Ye; Xiaofeng Jin
Journal:  J Mol Med (Berl)       Date:  2022-07-11       Impact factor: 5.606

9.  Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults.

Authors:  K B Onel; D Huo; D Hastings; J Fryer-Biggs; M K Crow; K Onel
Journal:  Lupus       Date:  2009-01       Impact factor: 2.911

10.  Insights into endometrial serous carcinogenesis and progression.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2009-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.